Literature DB >> 4552465

Cell-mediated immunity in Herpesvirus hominis infections.

J M Wilton, L Ivanyi, T Lehner.   

Abstract

The cell-mediated and antibody responses to Herpesvirus hominis type 1 were investigated in patients with primary and recurrent herpetic infections. Stimulation of lymphocyte transformation with the virus and the complement fixing antibody titre did not differ significantly between patients and controls. However, macrophage migration inhibition and lymphocyte cytotoxicity were impaired in patients. The defects were specific to H. hominis, as Candida oblicans, which was used as an unrelated antigen, failed to show a similar abnormality. These results and preliminary sequential studies suggest that the susceptibility to recurrent herpesvirus infection may be due to an impaired production of macrophage migration inhibition factor and lymphocyte cytotoxicity in the presence of intact lymphocyte sensitization and antibody formation.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4552465      PMCID: PMC1787644          DOI: 10.1136/bmj.1.5802.723

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  18 in total

1.  A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans.

Authors:  R G Douglas; R B Couch
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

2.  Lymphocyte transformation in patients with amyloidosis.

Authors:  T Lehner; J S Cameron; R G Ward
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

3.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

4.  The incidence of Herpesvirus hominis antibody in the population.

Authors:  I W Smith; J F Peutherer; F O MacCallum
Journal:  J Hyg (Lond)       Date:  1967-09

5.  Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity.

Authors:  M D Cooper; H P Chae; J T Lowman; W Krivit; R A Good
Journal:  Am J Med       Date:  1968-04       Impact factor: 4.965

6.  The cellular immune defect in chronic mucocutaneous candidiasis.

Authors:  R A Chilgren; H J Meuwissen; P G Quie; R A Good; R Hong
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

7.  Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes.

Authors:  P Perlmann; H Perlmann; G Holm
Journal:  Science       Date:  1968-04-19       Impact factor: 47.728

8.  Cell migration inhibition factor released by antigen from human peripheral lymphocytes.

Authors:  D E Thor; R E Jureziz; S R Veach; E Miller; S Dray
Journal:  Nature       Date:  1968-08-17       Impact factor: 49.962

9.  An in vitro assay for cellular hypersensitivity in man.

Authors:  R E Rocklin; O L Meyers; J R David
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

10.  Immunological relevance of antigen and antigen antibody complex induced lymphocyte transformation.

Authors:  J J Oppenheim
Journal:  Ann Allergy       Date:  1969-07
View more
  49 in total

Review 1.  The fifth Frederick H. Verhoeff Lecture. The role of the lymphocyte (cell-mediated) immunity in ocular disease.

Authors:  I H Leopold
Journal:  Trans Am Ophthalmol Soc       Date:  1973

2.  Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.

Authors:  L A Babiuk; B T Rouse
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

3.  Animal studies on the efficacy of an inactivated herpes simplex virus vaccine against recurrent herpes infection.

Authors:  M Scriba
Journal:  Infection       Date:  1978       Impact factor: 3.553

4.  The essentials of data sources in eye epidemiology.

Authors:  T Tokumaru; S Austin-Sweeney
Journal:  Doc Ophthalmol       Date:  1976-03-31       Impact factor: 2.379

5.  Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.

Authors:  Y H Thong; M M Vincent; S A Hensen; D A Fuccillo; M Rola-Pleszczynski; J A Bellanti
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

6.  Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

Authors:  A S Russell; J S Percy; T Kovithavongs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

7.  Stimulation of human lymphocytes by Herpes simplex virus antigens.

Authors:  S E Starr; S A Karatela; S L Shore; A Duffey; A J Nahmias
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

8.  Plaque size reduction as a measure of viral cell-mediated immunity.

Authors:  R L Simmons; Y Centifanto; H E Kaufman
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

9.  Pathogenetic mechansims of recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

10.  Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares.

Authors:  S K Dutta; D L Campbell
Journal:  Can J Comp Med       Date:  1977-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.